MedTrace Logo

Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease

NCT05643365 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-10-12

No results posted yet for this study

Summary

The purpose of this retrospective study was to clarify the possible risk factors of early hypothyroidism after RAI therapy in Graves' disease.

Conditions

  • Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients

Interventions

RADIATION

Radioactive Iodine therapy

All the patient need to stop ATD and iodine-containing drugs for 5 days prior to RAI treatment, and followed a low-iodine diet for 2 weeks. After fasting and water deprivation for 8 h, all the patients took RAI orally in the morning. After taking RAI, the patients need to continue fasting and water deprivation for extra 2 h to avoid the effects of food on iodine absorption.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hemat A Mahmoud, M.D · Lecturer

  • Hanan G Mostafa, M.D · Professor

Eligibility

Min Age
13 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2022-11-01
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05643365 on ClinicalTrials.gov